LANTHEUS HOLDINGS INC
NASDAQ: LNTH (Lantheus Holdings, Inc.)
Kemas kini terakhir: semalam, 4:22AM100.97
-0.01 (-0.01%)
| Penutupan Terdahulu | 100.98 |
| Jumlah Dagangan | 833,218 |
| Harga / Pendapatan (P/E Ke hadapan) | 14.41 |
| Harga / Jualan (P/S) | 4.29 |
| Harga / Buku (P/B) | 5.02 |
| Julat 52 Minggu |
| Margin Keuntungan | 16.55% |
| Margin Operasi (TTM) | 27.38% |
| EPS Cair (TTM) | 3.51 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 0.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -44.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 52.78% |
| Nisbah Semasa (MRQ) | 5.74 |
| Aliran Tunai Operasi (OCF TTM) | 525.08 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 241.87 M |
| Pulangan Atas Aset (ROA TTM) | 14.39% |
| Pulangan Atas Ekuiti (ROE TTM) | 24.11% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Lantheus Holdings, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Purata | -1.10 |
|
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 2.24% |
| % Dimiliki oleh Institusi | 116.12% |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| MARSHALL ROBERT J. JR. | - | 100.96 | -721 | -72,792 |
| Jumlah Keseluruhan Kuantiti Bersih | -721 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -72,792 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 100.96 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| MARSHALL ROBERT J. JR. | Pegawai | 31 Aug 2026 | Dibuang (-) | 721 | 100.96 | 72,792 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |